Malcolm Johnson - Concepedia

Author

Malcolm Johnson

Also Known As

JOHNSON M., Johnson,Malcolm, M Johnson, M. JOHNSON, M. Johnson, M. W. Johnson, M.W. Johnson, MALCOLM JOHNSON, Malcolm Johnson, Malcolm W. Johnson

139

Publications

7.7K

Citations

H-Index

Concepts

All Affiliations

GlaxoSmithKline (United Kingdom)Imperial College London University of Hertfordshire University of Calgary Lung Institute

About

Malcolm Johnson is an author at GlaxoSmithKline (United Kingdom) specializing in medicine, pharmacology, and lung inflammation.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	20	27	1.8K
2	Allergy	8	8	549
3	Health Sciences	3	3	163
4	Natural Sciences	1	1	156
5	Allergy Medicine	1	1	28

Malcolm Johnson

Publications

4.4K

Citations

H-Index

Page 1

	Year	Citations
Experimental Rhinovirus Infection as a Human Model of Chronic Obstructive Pulmonary Disease Exacerbation Patrick Mallia, Simon Message, Vera Gielen, American Journal of Respiratory and Critical Care Medicine	2010	404
Ligand-independent Activation of the Glucocorticoid Receptor by β2-Adrenergic Receptor Agonists in Primary Human Lung Fibroblasts and Vascular Smooth Muscle Cells Oliver Eickelberg, Michael Roth, Rainer Lörx, Journal of Biological Chemistry	1999	378
Rhinovirus Infection Induces Degradation of Antimicrobial Peptides and Secondary Bacterial Infection in Chronic Obstructive Pulmonary Disease Patrick Mallia, Joseph Footitt, Rosa Sotero, American Journal of Respiratory and Critical Care Medicine	2012	268
Antiinflammatory Effects of Salmeterol/Fluticasone Propionate in Chronic Obstructive Lung Disease Neil Barnes, Yusheng Qiu, Ian Pavord, American Journal of Respiratory and Critical Care Medicine	2006	251
Glucocorticoid Receptor Nuclear Translocation in Airway Cells after Inhaled Combination Therapy Omar S. Usmani, Kazuhiro Ito, Kittipong Maneechotesuwan, American Journal of Respiratory and Critical Care Medicine AsthmaInflammatory Lung DiseaseHealthy SubjectsLung InflammationGlucocorticoid	2005	224
Cigarette smoke increases Toll‐like receptor 4 and modifies lipopolysaccharide‐mediated responses in airway epithelial cells Elisabetta Pace, Maria Ferraro, Liboria Siena, Immunology AsthmaLung InflammationImmunologyInnate ImmunityCigarette Smoke	2008	202
Salmeterol, a novel, long‐acting β<sub>2</sub>‐adrenoceptor agonist: characterization of pharmacological activity<i>in vitro</i>and<i>in vivo</i> D.I. Ball, R T Brittain, Robert A. Coleman, British Journal of Pharmacology	1991	184
Salmeterol: a potent and long‐acting inhibitor of inflammatory mediator release from human lung Peter R. Butchers, C.J. Vardey, Malcolm Johnson British Journal of Pharmacology	1991	158
Sustained Activation of a G Protein-coupled Receptor via “Anchored” Agonist Binding Stuart A. Green, Andrew P. Spasoff, Robert A. Coleman, Journal of Biological Chemistry Molecular BiologyInherent Therapeutic LimitationRapid DissociationMolecular PharmacologyCell Signaling	1996	156
Combination Therapy Michael R. Edwards, Malcolm Johnson, Sebastian L. Johnston American Journal of Respiratory Cell and Molecular Biology AsthmaInflammationCytokineInflammatory Lung DiseaseRhinovirus 16	2006	105

Page 1